Rare diseases
Investigational molecules
Locations
Back to France1 490 clinical trials in Marseille, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Ezabenlimab and Drug Combination for Stage III Anal Cancer Treatment
FranceStudy on Post-Operative Chemotherapy with Doxorubicin and Trabectedin for Patients with High-Risk Localized Uterine Leiomyosarcoma
FranceStudy on Stopping Prednisolone Early in Patients with Negative FDG-PET/CT and Idiopathic Retroperitoneal Fibrosis
FranceStudy of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability
FranceStudy on Riluzole for Reducing Spasticity in Patients with Chronic Spinal Cord Injury
FranceStudy on the Early Use of Levosimendan Compared to Placebo for Patients with Cardiogenic Shock
FranceStudy on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms
FranceLong-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
FranceStudy on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System
FranceStudy on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer
FranceStudy of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer
FranceStudy on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on innovative treatments for head and neck squamous cell carcinoma, examining novel therapies and combinations with radiotherapy. Research includes investigations into endometrial cancer and bladder cancer treatments.
Particular emphasis on combining immunotherapy with conventional treatments for improved patient outcomes.
Innovative research addressing heart failure prevention and treatment of acute myocardial infarction. Studies include new approaches for managing hypertriglyceridemia and chronic kidney disease.
Focus on developing novel therapeutic approaches and improving patient outcomes in cardiovascular health.
Clinical investigations into multiple sclerosis treatment strategies and management of essential tremor. Research includes innovative approaches for Dravet Syndrome and neurological disorders.
Emphasis on developing targeted therapies for various neurological conditions affecting both adults and children.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
